会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明授权
    • Insulin highly respirable microparticles
    • 胰岛素高度可呼吸的微粒
    • US07625865B2
    • 2009-12-01
    • US10593861
    • 2004-03-26
    • Paolo ColomboStefano CagnaniPaolo Ventura
    • Paolo ColomboStefano CagnaniPaolo Ventura
    • A61K38/28A61K51/12
    • A61K9/0075A61K9/1688A61K38/28
    • The invention describes novel dried powders of peptide therapeutic agent useful for producing highly respirable aerosols and the methods for their manufacture. Insulin is the peptide therapeutic agent in the preferred embodiment. The powders of insulin prepared for pulmonary administration are characterized by the peculiar structure and shape of the microparticles that allow the powder to flow and to be easy aerosolized. Typical dry powder of insulin described in this patent show corrugated, nonagglomerated microparticles with a low tapped density. The mean geometric diameter (particle size) ranges between 1.0 and 10.0 micron and the mass median aerodynamic diameter (MMAD) ranges between 1.0 and 4.0 micron. These insulin pulmonary powders exhibit in vitro a very high respirable fraction (>75%).
    • 本发明描述了用于生产高吸入性气溶胶的肽治疗剂的新颖干粉及其制备方法。 胰岛素是优选实施方案中的肽治疗剂。 制备用于肺部给药的胰岛素粉末的特征在于允许粉末流动并易于雾化的微粒的特殊结构和形状。 在该专利中描述的典型的胰岛素干粉末显示具有低抽头密度的波纹状,非团聚微粒。 平均几何直径(粒径)在1.0和10.0微米之间,质量中值空气动力学直径(MMAD)在1.0和4.0微米之间。 这些胰岛素肺粉末在体外表现出非常高的可呼吸分数(> 75%)。
    • 10. 发明申请
    • Insulin highly respirable microparticles
    • 胰岛素高度可呼吸的微粒
    • US20070154404A1
    • 2007-07-05
    • US10593861
    • 2004-03-26
    • Paolo ColomboStefano CagnaniPaolo Ventura
    • Paolo ColomboStefano CagnaniPaolo Ventura
    • A61K38/28A61K9/14
    • A61K9/0075A61K9/1688A61K38/28
    • The invention describes novel dried powders of peptide therapeutic agent useful for producing highly respirable aerosols and the methods for their manufacture. Insulin is the peptide therapeutic agent in the preferred embodiment. The powders of insulin prepared for pulmonary administration are characterized by the peculiar structure and shape of the microparticles that allow the powder to flow and to be easy aerosolized. Typical dry powder of insulin described in this patent show corrugated, nonagglomerated microparticles with a low tapped density. The mean geometric diameter (particle size) ranges between 1.0 and 10.0 micron and the mass median aerodynamic diameter (MMAD) ranges between 1.0 and 4.0 micron. These insulin pulmonary powders exhibit in vitro a very high respirable fraction (>75%).
    • 本发明描述了用于生产高吸入性气溶胶的肽治疗剂的新颖干粉及其制备方法。 胰岛素是优选实施方案中的肽治疗剂。 制备用于肺部给药的胰岛素粉末的特征在于允许粉末流动并易于雾化的微粒的特殊结构和形状。 在该专利中描述的典型的胰岛素干粉末显示具有低抽头密度的波纹状,非团聚微粒。 平均几何直径(粒径)在1.0和10.0微米之间,质量中值空气动力学直径(MMAD)在1.0和4.0微米之间。 这些胰岛素肺粉末在体外表现出非常高的可呼吸分数(> 75%)。